Although endometrioid endometrial cancer (EEC; comprising~ 80% of all endometrial
cancers diagnosed) is typically associated with favourable patient outcome, a significant …

Endometrial cancer (EC) incidence and mortality continues to rise. Molecular profiling of EC
promises improvement of risk assessment and treatment selection. However, we still lack …

Endometrial cancer is the most common gynecologic malignancy in the United States but it
remains poorly understood at the molecular level. This investigation was conducted to …

Simple Summary Endometrial carcinomas (EC) have been traditionally classified based on
histopathology (types I and II). Determining the risk of a patient to experience disease …

Background Despite recent advances in endometrial carcinoma (EC) molecular
characterization, its prognostication remains challenging. We aimed to assess whether …

Objectives Recent data support the predictive implications of molecular subtype assignment
in endometrial cancer (EC). Our objective was to retrospectively assess clinical outcomes …

Background and Objective Endometrial cancer (EC) is a common gynecological malignancy
worldwide. Despite advances in the development of strategies for treating EC, prognosis of …

Simple Summary Implementing machine learning methods into the RNA-seq data analysis
pipelines can further improve the efficiency of data utilization in clinical decision making. In …

Background The molecular profile of endometrial cancer has become an important tool in
determining patient prognosis and their optimal adjuvant treatment. In addition to The …

Background Endometrial cancer is the most common gynecologic malignancy in developed
countries and little is known about the underlying mechanism of stage and disease …